Qiagen NV at Barclays Global Healthcare Conference Transcript
Good morning, everybody. I'm Luke Sergott. I cover life science tools and diagnostics for Barclays. Kicking off the conference here. First meeting with Qiagen. Long time listener, long time and caller, I guess for me. I have Roland Sackers, CFO, and Daniel Wendorff, IR.
Questions & Answers
I guess just to start off. We talked about this a little bit outside, but kind of go through updates on strategic direction, CEO search, some of the M&A news that's been out there. So just kind of wrap all that up into some early comments.
Yeah. First of all, thanks for having us and I appreciate that you're now a research analyst and not a researcher anymore. We still miss you as a customer. But I think it's an important question, and I think probably you're referring to also the comments that he made more or less last week
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
